I come to CUMC with almost 20 years of clinical expertise in molecular pathology including teaching and scholarly activity at Rutgers University and Weill Cornell Medicine. Over the years, I have developed, validated and implemented clinical molecular assays for oncology, genetics and infectious diseases. My current role in the laboratory of Personalized Genomics Medicine involves the validation and application of clinical assays for the interrogation of genomic variants in oncology. The translational research projects that I participate in, deal with understanding the role of oncogenic variants in the diagnostic classification and progression of disease for the advancement of Precision Medicine. I am significantly involved in the training, education and mentoring of molecular diagnosticians, pathology residents and fellows. My interests also lie in promoting the scope and quality aspects of molecular pathology at the global level. This involves participating in the accreditation of clinical laboratories and organizing symposia that address validation and quality control of laboratory developed tests in molecular pathology. I am an active member of the Association for Molecular Pathology (AMP) and American Association for Clinical Chemistry (AACC). I come to CUMC with almost 20 years of clinical expertise in molecular pathology including teaching and scholarly activity at Rutgers University and Weill Cornell Medicine. Over the years, I have developed, validated and implemented clinical molecular assays for oncology, genetics and infectious diseases. My current role in the laboratory of Personalized Genomics Medicine involves the validation and application of clinical assays for the interrogation of genomic variants in oncology. The translational research projects that I participate in, deal with understanding the role of oncogenic variants in the diagnostic classification and progression of disease for the advancement of Precision Medicine. I am significantly involved in the training, education and mentoring of molecular diagnosticians, pathology residents and fellows. My interests also lie in promoting the scope and quality aspects of molecular pathology at the global level. This involves participating in the accreditation of clinical laboratories and organizing symposia that address validation and quality control of laboratory developed tests in molecular pathology. I am an active member of the Association for Molecular Pathology (AMP) and American Association for Clinical Chemistry (AACC).

Pathology and Cell Biology